Fluoroquinolones in the Treatment of Tuberculosis: A Study in Mice

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 3, 2004, Pages 334-335

  Mitchison, Denis A ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; DISEASE MODEL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COMBINATION; DRUG INDICATION; DRUG SAFETY; EDITORIAL; EXPERIMENTAL INFECTION; EXPERIMENTAL MOUSE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SHORT COURSE THERAPY; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; MICE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 1642578221     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2004;169:421-426.
2. O'Brien R. Development of fluoroquinolones as first-line drugs for tuberculosis - at long last! Am J Respir Crit Care Med 2003;168:1-2.
3. Weber WW, Hein DW. Section 4. Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet 1979;4:401-422.
4. Dickinson J, Guy A, Mitchison DA. Bioavailability of rifampicin in experimental murine tuberculosis. Antimicrob Agents Chemother 1992;36: 2066-2067.
5. Jindani A, Doré CJ, Mitchison DA. The bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003;167:1348-1354.
6. Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Hatfull GF, Jacobs WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press: 2000. p. 235-254.
7. Hu Y, Coates ARM, Mitchison DA. Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003;47:653-657.
8. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000;4:796-806.
9. Global Alliance for Tuberculosis Drug Development. Tuberculosis scientific blueprint for TB drug development. Tuberculosis (Edinb) 2001; 81(Supp 1): 1-52.